Clinitech Laboratory Ltd Financials
Company Logo

Clinitech Laboratory Ltd Financial Statement

Clinitech Laboratory Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Invest in Clinitech Laboratory Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Clinitech Laboratory Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual6.40
Operating Expenses Annual5.42
Operating Profit Annual1.02
Interest Annual0.07
Depreciation0.44
Net Profit Annual0.37
Tax Annual0.13

Clinitech Laboratory Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.78
Cash Flow from Operations0.11
Cash Flow from Investing-0.64
Cash Flow from Financing0.45
Cash Flow at the End0.70

Clinitech Laboratory Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)16.09
PBIT Margin (%)9.22
PBT Margin (%)-93.28
Net PROFIT Margin (%)5.78
Return On Networth / Equity (%)12.48
Return On Networth /Employed (%)12.25
Return On Assets (%)7.69
Total Debt / Equity (X)0.32
Asset Turnover Ratio (%)1.33

Clinitech Laboratory Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual2.66
Total Current Assets Annual2.71
Non Current Assets Annual2.90
Total Shareholders Funds Annual3.55
Total Assets Annual5.61

Clinitech Laboratory Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 22, 2024, Clinitech Laboratory Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Clinitech Laboratory Ltd is debt-free with a debt-to-equity ratio of 0.24.
In FY 2023 , Clinitech Laboratory Ltd recorded a total revenue of approximately 6.40 Cr marking a significant milestone in the company's financial performance.
Clinitech Laboratory Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.0% annually, respectively..
Clinitech Laboratory Ltd's current PE ratio is undefined.
Clinitech Laboratory Ltd's ROCE averaged 19.9% from the FY ending March 2022 to 2024, with a median of 18.8%. It peaked at 27.7% in March 2022, reflecting strong capital efficiency over the period..
Clinitech Laboratory Ltd's latest EBIT is Rs. 0.58 Cr, surpassing the average EBIT of Rs. 0.75 Cr over the 5 years..